GeneDx (NASDAQ:WGS – Free Report) had its price target lifted by TD Cowen from $14.00 to $24.00 in a research note released on Tuesday, Benzinga reports. They currently have a buy rating on the stock. A number of other analysts have also weighed in on WGS. BTIG Research increased their price objective on shares of […]

Related Keywords

Katherine Stueland , Genedx Holdings Corp , Hightower Advisors , Securities Exchange Commission , Trellus Management Company , Goldman Sachs Group , Casdin Capital Llc , Pathstone Family Office , Thompson Davis , Genedx Company Profile , Free Report , Get Free Report , Director Casdin Capital , Exchange Commission , Tower Advisors , Family Office , Management Company , Genedx Daily ,